棕榈酰化
车站3
细胞生物学
STAT蛋白
癌症研究
生物
细胞因子
化学
信号转导
酪氨酸磷酸化
原癌基因酪氨酸蛋白激酶Src
癌变
生物化学
免疫学
酶
基因
半胱氨酸
作者
Jixiao Niu,Yang Sun,Baoen Chen,Baohui Zheng,Gopala K. Jarugumilli,Sarah R. Walker,Aaron N. Hata,Mari Mino‐Kenudson,David A. Frank,Xu Wu
出处
期刊:Nature
[Springer Nature]
日期:2019-08-28
卷期号:573 (7772): 139-143
被引量:51
标识
DOI:10.1038/s41586-019-1511-x
摘要
Signal transducer and activator of transcription 3 (STAT3) has a critical role in regulating cell fate, inflammation and immunity1,2. Cytokines and growth factors activate STAT3 through kinase-mediated tyrosine phosphorylation and dimerization3,4. It remains unknown whether other factors promote STAT3 activation through different mechanisms. Here we show that STAT3 is post-translationally S-palmitoylated at the SRC homology 2 (SH2) domain, which promotes the dimerization and transcriptional activation of STAT3. Fatty acids can directly activate STAT3 by enhancing its palmitoylation, in synergy with cytokine stimulation. We further identified ZDHHC19 as a palmitoyl acyltransferase that regulates STAT3. Cytokine stimulation increases STAT3 palmitoylation by promoting the association between ZDHHC19 and STAT3, which is mediated by the SH3 domain of GRB2. Silencing ZDHHC19 blocks STAT3 palmitoylation and dimerization, and impairs the cytokine- and fatty-acid-induced activation of STAT3. ZDHHC19 is frequently amplified in multiple human cancers, including in 39% of lung squamous cell carcinomas. High levels of ZDHHC19 correlate with high levels of nuclear STAT3 in patient samples. In addition, knockout of ZDHHC19 in lung squamous cell carcinoma cells significantly blocks STAT3 activity, and inhibits the fatty-acid-induced formation of tumour spheres as well as tumorigenesis induced by high-fat diets in an in vivo mouse model. Our studies reveal that fatty-acid- and ZDHHC19-mediated palmitoylation are signals that regulate STAT3, which provides evidence linking the deregulation of palmitoylation to inflammation and cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI